These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19324273)

  • 21. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.
    Hausner SH; Kukis DL; Gagnon MK; Stanecki CE; Ferdani R; Marshall JF; Anderson CJ; Sutcliffe JL
    Mol Imaging; 2009; 8(2):111-21. PubMed ID: 19397856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [(68)Ga]FSC-(RGD)3 a trimeric RGD peptide for imaging αvβ3 integrin expression based on a novel siderophore derived chelating scaffold-synthesis and evaluation.
    Knetsch PA; Zhai C; Rangger C; Blatzer M; Haas H; Kaeopookum P; Haubner R; Decristoforo C
    Nucl Med Biol; 2015 Feb; 42(2):115-22. PubMed ID: 25459110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligands for mapping alphavbeta3-integrin expression in vivo.
    Schottelius M; Laufer B; Kessler H; Wester HJ
    Acc Chem Res; 2009 Jul; 42(7):969-80. PubMed ID: 19489579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [68Ga]NODAGA-RGD for imaging αvβ3 integrin expression.
    Knetsch PA; Petrik M; Griessinger CM; Rangger C; Fani M; Kesenheimer C; von Guggenberg E; Pichler BJ; Virgolini I; Decristoforo C; Haubner R
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1303-12. PubMed ID: 21487838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.
    Cai W; Chen K; Li ZB; Gambhir SS; Chen X
    J Nucl Med; 2007 Nov; 48(11):1862-70. PubMed ID: 17942800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides.
    Jacobson O; Zhu L; Niu G; Weiss ID; Szajek LP; Ma Y; Sun X; Yan Y; Kiesewetter DO; Liu S; Chen X
    Mol Imaging Biol; 2011 Dec; 13(6):1224-33. PubMed ID: 21161690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
    Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
    Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging.
    Liu S; Liu H; Jiang H; Xu Y; Zhang H; Cheng Z
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1732-41. PubMed ID: 21617974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64.
    Jensen AI; Binderup T; Kumar EK P; Kjær A; Rasmussen PH; Andresen TL
    Biomacromolecules; 2014 May; 15(5):1625-33. PubMed ID: 24645913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers.
    Shi J; Kim YS; Chakraborty S; Zhou Y; Wang F; Liu S
    Amino Acids; 2011 Nov; 41(5):1059-70. PubMed ID: 20052508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of copper-64 labeled AmBaSar conjugated cyclic RGD peptide for improved microPET imaging of integrin alphavbeta3 expression.
    Cai H; Li Z; Huang CW; Shahinian AH; Wang H; Park R; Conti PS
    Bioconjug Chem; 2010 Aug; 21(8):1417-24. PubMed ID: 20666401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression.
    Decristoforo C; Hernandez Gonzalez I; Carlsen J; Rupprich M; Huisman M; Virgolini I; Wester HJ; Haubner R
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1507-15. PubMed ID: 18369617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
    Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
    Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of ⁶⁸Ga-TRAP(RGD)₃.
    Notni J; Pohle K; Wester HJ
    Nucl Med Biol; 2013 Jan; 40(1):33-41. PubMed ID: 22995902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4).
    Wu Z; Li ZB; Chen K; Cai W; He L; Chin FT; Li F; Chen X
    J Nucl Med; 2007 Sep; 48(9):1536-44. PubMed ID: 17704249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroPET imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides.
    Chen X; Liu S; Hou Y; Tohme M; Park R; Bading JR; Conti PS
    Mol Imaging Biol; 2004; 6(5):350-9. PubMed ID: 15380745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.
    Guo Y; Ferdani R; Anderson CJ
    Bioconjug Chem; 2012 Jul; 23(7):1470-7. PubMed ID: 22663248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aptamer imaging with Cu-64 labeled AS1411: preliminary assessment in lung cancer.
    Li J; Zheng H; Bates PJ; Malik T; Li XF; Trent JO; Ng CK
    Nucl Med Biol; 2014 Feb; 41(2):179-85. PubMed ID: 24373858
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.